Poractant alfa (Curosurf<sup>®</sup>) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo

<p>Abstract</p> <p>Background</p> <p>Clearance of apoptotic neutrophils in the lung is an essential process to limit inflammation, since they could become a pro-inflammatory stimulus themselves. The clearance is partially mediated by alveolar macrophages, which phagocyt...

Full description

Bibliographic Details
Main Authors: Willems Coen HMP, Urlichs Florian, Seidenspinner Silvia, Kunzmann Steffen, Speer Christian P, Kramer Boris W
Format: Article
Language:English
Published: BMC 2012-03-01
Series:Respiratory Research
Subjects:
Online Access:http://respiratory-research.com/content/13/1/17
id doaj-ff8ab9ee1c0b47dfba430f8a467af0da
record_format Article
spelling doaj-ff8ab9ee1c0b47dfba430f8a467af0da2020-11-24T21:16:06ZengBMCRespiratory Research1465-99212012-03-011311710.1186/1465-9921-13-17Poractant alfa (Curosurf<sup>®</sup>) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivoWillems Coen HMPUrlichs FlorianSeidenspinner SilviaKunzmann SteffenSpeer Christian PKramer Boris W<p>Abstract</p> <p>Background</p> <p>Clearance of apoptotic neutrophils in the lung is an essential process to limit inflammation, since they could become a pro-inflammatory stimulus themselves. The clearance is partially mediated by alveolar macrophages, which phagocytose these apoptotic cells. The phagocytosis of apoptotic immune cells by monocytes in vitro has been shown to be augmented by several constituents of pulmonary surfactant, e.g. phospholipids and hydrophobic surfactant proteins. In this study, we assessed the influence of exogenous poractant alfa (Curosurf<sup>®</sup>) instillation on the in vivo phagocytosis of apoptotic neutrophils by alveolar macrophages.</p> <p>Methods</p> <p>Poractant alfa (200 mg/kg) was instilled intratracheally in the lungs of three months old adult male C57/Black 6 mice, followed by apoptotic neutrophil instillation. Bronchoalveloar lavage was performed and alveolar macrophages and neutrophils were counted. Phagocytosis of apoptotic neutrophils was quantified by determining the number of apoptotic neutrophils per alveolar macrophages.</p> <p>Results</p> <p>Exogenous surfactant increased the number of alveolar macrophages engulfing apoptotic neutrophils 2.6 fold. The phagocytosis of apoptotic neutrophils was increased in the presence of exogenous surfactant by a 4.7 fold increase in phagocytosed apoptotic neutrophils per alveolar macrophage.</p> <p>Conclusions</p> <p>We conclude that the anti-inflammatory properties of surfactant therapy may be mediated in part by increased numbers of alveolar macrophages and increased phagocytosis of apoptotic neutrophils by alveolar macrophages.</p> http://respiratory-research.com/content/13/1/17InflammationResolutionAnti inflammationDrug therapySurfactant
collection DOAJ
language English
format Article
sources DOAJ
author Willems Coen HMP
Urlichs Florian
Seidenspinner Silvia
Kunzmann Steffen
Speer Christian P
Kramer Boris W
spellingShingle Willems Coen HMP
Urlichs Florian
Seidenspinner Silvia
Kunzmann Steffen
Speer Christian P
Kramer Boris W
Poractant alfa (Curosurf<sup>®</sup>) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo
Respiratory Research
Inflammation
Resolution
Anti inflammation
Drug therapy
Surfactant
author_facet Willems Coen HMP
Urlichs Florian
Seidenspinner Silvia
Kunzmann Steffen
Speer Christian P
Kramer Boris W
author_sort Willems Coen HMP
title Poractant alfa (Curosurf<sup>®</sup>) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo
title_short Poractant alfa (Curosurf<sup>®</sup>) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo
title_full Poractant alfa (Curosurf<sup>®</sup>) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo
title_fullStr Poractant alfa (Curosurf<sup>®</sup>) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo
title_full_unstemmed Poractant alfa (Curosurf<sup>®</sup>) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo
title_sort poractant alfa (curosurf<sup>®</sup>) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo
publisher BMC
series Respiratory Research
issn 1465-9921
publishDate 2012-03-01
description <p>Abstract</p> <p>Background</p> <p>Clearance of apoptotic neutrophils in the lung is an essential process to limit inflammation, since they could become a pro-inflammatory stimulus themselves. The clearance is partially mediated by alveolar macrophages, which phagocytose these apoptotic cells. The phagocytosis of apoptotic immune cells by monocytes in vitro has been shown to be augmented by several constituents of pulmonary surfactant, e.g. phospholipids and hydrophobic surfactant proteins. In this study, we assessed the influence of exogenous poractant alfa (Curosurf<sup>®</sup>) instillation on the in vivo phagocytosis of apoptotic neutrophils by alveolar macrophages.</p> <p>Methods</p> <p>Poractant alfa (200 mg/kg) was instilled intratracheally in the lungs of three months old adult male C57/Black 6 mice, followed by apoptotic neutrophil instillation. Bronchoalveloar lavage was performed and alveolar macrophages and neutrophils were counted. Phagocytosis of apoptotic neutrophils was quantified by determining the number of apoptotic neutrophils per alveolar macrophages.</p> <p>Results</p> <p>Exogenous surfactant increased the number of alveolar macrophages engulfing apoptotic neutrophils 2.6 fold. The phagocytosis of apoptotic neutrophils was increased in the presence of exogenous surfactant by a 4.7 fold increase in phagocytosed apoptotic neutrophils per alveolar macrophage.</p> <p>Conclusions</p> <p>We conclude that the anti-inflammatory properties of surfactant therapy may be mediated in part by increased numbers of alveolar macrophages and increased phagocytosis of apoptotic neutrophils by alveolar macrophages.</p>
topic Inflammation
Resolution
Anti inflammation
Drug therapy
Surfactant
url http://respiratory-research.com/content/13/1/17
work_keys_str_mv AT willemscoenhmp poractantalfacurosurfsupsupincreasesphagocytosisofapoptoticneutrophilsbyalveolarmacrophagesinvivo
AT urlichsflorian poractantalfacurosurfsupsupincreasesphagocytosisofapoptoticneutrophilsbyalveolarmacrophagesinvivo
AT seidenspinnersilvia poractantalfacurosurfsupsupincreasesphagocytosisofapoptoticneutrophilsbyalveolarmacrophagesinvivo
AT kunzmannsteffen poractantalfacurosurfsupsupincreasesphagocytosisofapoptoticneutrophilsbyalveolarmacrophagesinvivo
AT speerchristianp poractantalfacurosurfsupsupincreasesphagocytosisofapoptoticneutrophilsbyalveolarmacrophagesinvivo
AT kramerborisw poractantalfacurosurfsupsupincreasesphagocytosisofapoptoticneutrophilsbyalveolarmacrophagesinvivo
_version_ 1726017112183406592